- Home
- EXAS vs WBS Comparison
EXAS vs WBS Comparison
Compare EXAS & WBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- WBS
- Stock Information
- Founded
- EXAS 1995
- WBS 1935
- Country
- EXAS United States
- WBS United States
- Employees
- EXAS N/A
- WBS N/A
- Industry
- EXAS Medical Specialities
- WBS Major Banks
- Sector
- EXAS Health Care
- WBS Finance
- Exchange
- EXAS Nasdaq
- WBS Nasdaq
- Market Cap
- EXAS 10.7B
- WBS 9.1B
- IPO Year
- EXAS N/A
- WBS N/A
- Fundamental
- Price
- EXAS $53.02
- WBS $52.01
- Analyst Decision
- EXAS Strong Buy
- WBS Strong Buy
- Analyst Count
- EXAS 20
- WBS 13
- Target Price
- EXAS $70.68
- WBS $63.38
- AVG Volume (30 Days)
- EXAS 2.9M
- WBS 1.3M
- Earning Date
- EXAS 07-30-2025
- WBS 06-30-2025
- Dividend Yield
- EXAS N/A
- WBS 3.08%
- EPS Growth
- EXAS N/A
- WBS N/A
- EPS
- EXAS N/A
- WBS 4.44
- Revenue
- EXAS $2,828,128,000.00
- WBS $2,372,492,000.00
- Revenue This Year
- EXAS $14.58
- WBS $9.68
- Revenue Next Year
- EXAS $12.75
- WBS $5.20
- P/E Ratio
- EXAS N/A
- WBS $11.62
- Revenue Growth
- EXAS 11.57
- WBS N/A
- 52 Week Low
- EXAS $39.97
- WBS $39.43
- 52 Week High
- EXAS $72.83
- WBS $63.99
- Technical
- Relative Strength Index (RSI)
- EXAS 45.95
- WBS 51.16
- Support Level
- EXAS $51.50
- WBS $53.51
- Resistance Level
- EXAS $53.30
- WBS $52.76
- Average True Range (ATR)
- EXAS 1.62
- WBS 1.05
- MACD
- EXAS -0.64
- WBS -0.30
- Stochastic Oscillator
- EXAS 26.95
- WBS 34.44
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.